- Home
- KNSA vs HURN Comparison
KNSA vs HURN Comparison
Compare KNSA & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- HURN
- Stock Information
- Founded
- KNSA 2015
- HURN 2002
- Country
- KNSA United Kingdom
- HURN United States
- Employees
- KNSA N/A
- HURN N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- HURN Professional Services
- Sector
- KNSA Health Care
- HURN Consumer Discretionary
- Exchange
- KNSA Nasdaq
- HURN Nasdaq
- Market Cap
- KNSA 2.6B
- HURN 2.6B
- IPO Year
- KNSA 2018
- HURN 2004
- Fundamental
- Price
- KNSA $38.51
- HURN $152.30
- Analyst Decision
- KNSA Strong Buy
- HURN Strong Buy
- Analyst Count
- KNSA 7
- HURN 4
- Target Price
- KNSA $44.00
- HURN $171.50
- AVG Volume (30 Days)
- KNSA 392.4K
- HURN 131.6K
- Earning Date
- KNSA 10-28-2025
- HURN 10-28-2025
- Dividend Yield
- KNSA N/A
- HURN N/A
- EPS Growth
- KNSA N/A
- HURN 37.96
- EPS
- KNSA 0.07
- HURN 5.74
- Revenue
- KNSA $529,332,000.00
- HURN $1,556,665,000.00
- Revenue This Year
- KNSA $37.21
- HURN $13.32
- Revenue Next Year
- KNSA $12.07
- HURN $8.31
- P/E Ratio
- KNSA $582.26
- HURN $26.52
- Revenue Growth
- KNSA 56.18
- HURN 9.24
- 52 Week Low
- KNSA $17.82
- HURN $102.95
- 52 Week High
- KNSA $39.12
- HURN $155.00
- Technical
- Relative Strength Index (RSI)
- KNSA 64.65
- HURN 69.62
- Support Level
- KNSA $37.69
- HURN $149.24
- Resistance Level
- KNSA $38.83
- HURN $153.19
- Average True Range (ATR)
- KNSA 0.95
- HURN 2.70
- MACD
- KNSA 0.00
- HURN 0.36
- Stochastic Oscillator
- KNSA 79.11
- HURN 76.49
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.